More about

Baricitinib

News
June 22, 2020
2 min read
Save

Brief hiatus in baricitinib therapy led to minor RA symptom recurrence

Brief hiatus in baricitinib therapy led to minor RA symptom recurrence

Short interruptions in baricitinib treatment are associated with minor increases in rheumatoid arthritis symptoms, which resolved after recontinuation, according to data published in Arthritis Research & Therapy.

News
March 16, 2020
1 min read
Save

Baricitinib receives breakthrough therapy designation for alopecia areata

The FDA granted breakthrough therapy designation to baricitinib to treat patients with alopecia areata, according to a press release from Eli Lilly and Incyte.

News
January 31, 2020
2 min read
Save

Baricitinib achieves primary endpoint in BREEZE-AD4, BREEZE-AD5 studies

Eli Lilly and Company and Incyte announced that baricitinib met its primary endpoint in the BREEZE-AD4 and BREEZE-AD5 studies in patients with moderate to severe atopic dermatitis, according to two press releases.

News
October 18, 2019
2 min read
Save

Baricitinib plus topical steroids improves atopic dermatitis symptoms

Combination treatment with baricitinib and topical corticosteroids was associated with a higher proportion of patients achieving clear or almost clear skin, according to data from the BREEZE-AD7 trial.

News
August 30, 2019
1 min read
Save

Glenmark receives FDA approval for generic atopic dermatitis cream

The FDA has granted final approval for pimecrolimus cream 1%, a generic form of Elidel, according to an announcement from Glenmark Pharmaceuticals.

News
June 26, 2023
3 min watch
Save

VIDEO: Benefits, concerns of JAK inhibitor use in RA

VIDEO: Benefits, concerns of JAK inhibitor use in RA

In this video, Kathryn Dao, MD, associate professor in the department of internal medicine’s division of rheumatology at UT Southwestern Medical Center, discussed the current state of JAK inhibitors as a newer development in RA treatment, and her approach towards prescribing them in the face of concerns about side effects.

News
June 23, 2023
1 min watch
Save

VIDEO: Baricitinib approval ‘major breakthrough’ for alopecia areata

VIDEO: Baricitinib approval ‘major breakthrough’ for alopecia areata

In this video, Carolyn Goh, MD, clinical associate professor in dermatology at David Geffen School of Medicine at UCLA, discusses the recent FDA approval ofbaricitinib (Olumiant, Lilly) for alopecia areata, which she calls a “major breakthrough for this disease."

News
June 23, 2023
2 min watch
Save

VIDEO: Alopecia areata ‘still a challenging disease’ despite available treatments

VIDEO: Alopecia areata ‘still a challenging disease’ despite available treatments

In this video,Carolyn Goh, MD, clinical associate professor in dermatology at David Geffen School of Medicine at UCLA, discusses the biggest challenges in alopecia areata care, including the lack treatment options for pediatric patients and the difficulty in obtaining insurance coverage for treatments.

News
June 19, 2023
1 min watch
Save

VIDEO: New advancements in alopecia areata treatment

VIDEO: New advancements in alopecia areata treatment

In this video, Benjamin Ungar, MD, Director of the Alopecia Center of Excellence at Mount Sinai Hospital, discusses some of the most recent advancements in the treatment and study of alopecia areata.

View more